Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Nanzer

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The European Respiratory Journal|February 26, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.
The European Respiratory Journal|July 20, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 31, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With BenralizumabDavid J Jackson, Hassan Burhan, Hitasha Rupani, et al.
European Journal of Endocrinology|July 27, 2006
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumoursErika Hubina, Alexandra M Nanzer, Matthew R Hanson, et al.
ERJ Open Research|June 3, 2026
Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma RegistryLeanne-Jo Holmes, Charlene Redmond, Liam Heaney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 11, 2024
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With PolyangiitisAlexandra M Nanzer, Anne-Catherine Maynard-Paquette, Vardah Alam, et al.
The Lancet. Respiratory Medicine|March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trialElaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The European Respiratory Journal|February 26, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.
The European Respiratory Journal|July 20, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 31, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With BenralizumabDavid J Jackson, Hassan Burhan, Hitasha Rupani, et al.
European Journal of Endocrinology|July 27, 2006
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumoursErika Hubina, Alexandra M Nanzer, Matthew R Hanson, et al.
ERJ Open Research|June 3, 2026
Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma RegistryLeanne-Jo Holmes, Charlene Redmond, Liam Heaney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 11, 2024
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With PolyangiitisAlexandra M Nanzer, Anne-Catherine Maynard-Paquette, Vardah Alam, et al.
The Lancet. Respiratory Medicine|March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trialElaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
Pageof 4